Compare CAG & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAG | BRKR |
|---|---|---|
| Founded | 1919 | 1960 |
| Country | United States | United States |
| Employees | 17400 | N/A |
| Industry | Packaged Foods | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 9.0B |
| IPO Year | 1994 | 2000 |
| Metric | CAG | BRKR |
|---|---|---|
| Price | $16.41 | $59.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 13 |
| Target Price | $16.88 | ★ $48.54 |
| AVG Volume (30 Days) | ★ 10.3M | 2.4M |
| Earning Date | 04-01-2026 | 05-06-2026 |
| Dividend Yield | ★ 9.84% | 0.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,500,000,000.00 | ★ $1,895,600,000.00 |
| Revenue This Year | N/A | $6.30 |
| Revenue Next Year | N/A | $3.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.53 | $28.53 |
| 52 Week High | $20.32 | $65.30 |
| Indicator | CAG | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 69.73 | 52.75 |
| Support Level | $15.96 | $54.54 |
| Resistance Level | $17.83 | $64.46 |
| Average True Range (ATR) | 0.40 | 2.86 |
| MACD | 0.10 | 0.26 |
| Stochastic Oscillator | 94.41 | 81.48 |
Conagra Brands Inc is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). The majority of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company sells through the USA retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.